WordNet
- any degenerative disorder resulting from inadequate or faulty nutrition
- a small yellowish central area of the retina that is rich in cones and that mediates clear detailed vision (同)macula_lutea, macular_area, yellow_spot
PrepTutorEJDIC
- 栄養障害 / 筋萎縮症,筋ジストロフィー(筋肉の退化・萎縮・運動障害などが起こる病気)
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/05/24 13:28:25」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 幹細胞の概要 overview of stem cells
English Journal
- Monitoring VEGF levels with low-volume sampling in major vision-threatening diseases: age-related macular degeneration and diabetic retinopathy.
- Hsu MY1, Chen SJ, Chen KH, Hung YC, Tsai HY, Cheng CM.
- Lab on a chip.Lab Chip.2015 Jun 7;15(11):2357-63. doi: 10.1039/c4lc01052c. Epub 2015 Apr 29.
- The purpose of this article is to demonstrate the capacity of paper-based ELISA (P-ELISA) to monitor VEGF in patients requiring treatment for vision-threatening diseases. The most commonly encountered vision-threatening diseases are age-related macular degeneration (AMD) and diabetic retinopathy (DR
- PMID 25923964
- Phospholipid-based self-assembled mesophase systems for light-activated drug delivery.
- Du JD1, Fong WK, Salentinig S, Caliph SM, Hawley A, Boyd BJ.
- Physical chemistry chemical physics : PCCP.Phys Chem Chem Phys.2015 Jun 7;17(21):14021-7. doi: 10.1039/c5cp01229e. Epub 2015 May 8.
- The manipulation of the structure of phospholipid-based mesophases to induce a slow to fast drug release profile has potential for use in therapeutic situations where continuous absorption of drug is not desirable and reduce the frequency of injection for short acting or rapidly cleared drugs in tre
- PMID 25953620
- Immunoactivation at the Crossroads of Human Disease.
- Margolis L1.
- The American journal of medicine.Am J Med.2015 Jun;128(6):562-566. doi: 10.1016/j.amjmed.2014.12.026. Epub 2015 Jan 28.
- It is becoming increasingly clear that immunoactivation, which evolved as a system of host defense against pathogens, can become dysregulated and promote the pathogenesis of diverse diseases with both known and unknown etiologies (eg, acquired immune deficiency syndrome, age-related macular degenera
- PMID 25637756
Japanese Journal
- 黄斑ジストロフィと自発蛍光 (特集 眼底自発蛍光と網膜臨床)
- 角田 和繁,藤波 芳
- 眼科 55(9), 1003-1008, 2013-09
- NAID 40019803525
- 臨床報告 慢性中心性漿液性脈絡網膜症と鑑別できた卵黄状黄斑ジストロフィの1例
- 小山田 紘,丸子 一朗,菅野 幸紀 [他]
- 眼科 55(3), 289-294, 2013-03
- NAID 40019624951
- 現代医学の焦点(364)三宅病研究の現状と展望
- 角田 和繁
- 日本臨床 71(2), 355-364, 2013-02
- NAID 40019565548
Related Links
- Macular dystrophy information. Types of macular dystrophies, new eye disease treatments and rehabilitation. Click here for info. ... Macular Dystrophy - Is There A Cure? Welcome to MacularDystrophy.net! On this site you will find ...
- Macular degeneration information. Eye disease types, new exciting macular degeneration treatments and possible cures. Click here for info. ... Macular Degeneration - Incredible New Cures For Macular Dystrophy, Wet AMD & Dry ...
Related Pictures
★リンクテーブル★
| リンク元 | 「黄斑変性」「黄斑ジストロフィー」 |
| 関連記事 | 「dystrophy」「macular」「macul」 |
「黄斑変性」
- 黄斑部に限局した網膜の変性をいうが、網膜全体に変性があり、その変化が特に黄斑部に強いものも黄斑変性と呼ぶ場合がある。
「黄斑ジストロフィー」
- 英
- macular dystrophy
- ラ
- dystrophia maculae luteae
- 同
- foveal dystrophy
- 関
- 黄斑変性症、黄斑変性
「dystrophy」
- n.
- (医)栄養失調、栄養失調症。(医)異栄養、異栄養症、ジフトロフィー
- 栄養障害。細胞や組織の物質代謝障害によって変性・萎縮などの起こること。
「macular」
- adj.
- 黄斑性の、黄斑の、斑の
「macul」
- 同
- maculo
- comb form
- 点、斑、斑紋、あざ、反転のある、斑点状の